AG Mednet, a leader in clinical trial workflow and process automation, is excited to announce the launch of AI-Assisted Redaction within its Judi platform. This powerful new capability leverages advanced artificial intelligence to streamline the process of identifying and redacting Protected Health Information (PHI), Personally Identifiable Information (PII) and other...
Radiology Partners (RP), the leading radiology practice in the U.S. through its owned and affiliated practices, and RADPAIR, a leader in generative AI-driven radiology solutions, today announced a strategic partnership to advance radiology innovation and address critical capacity challenges. The collaboration focuses on the co-development of advanced AI driven reporting tools...
Veeva Systems announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities, companies can deploy AI that will have immediate value...
TetraScience, the Scientific Data and AI Cloud, announced the launch of Chromatography Insights, the biopharmaceutical industry's first and only universal chromatography dashboard that seamlessly integrates data from any vendor's Chromatography Data System (CDS).
Chromatography data represents more than 50% of analytical data in therapeutic development and production. Yet, labs struggle...
TetraScience announced it is collaborating with NVIDIA to accelerate innovation in the $1.5 trillion life sciences industry by bringing standardization and scalability to the development and implementation of scientific AI.
The biopharma industry is racing to unlock AI’s potential across thousands of scientific use cases. However, millions of silos of...
Sorcero, a pioneer of AI-powered intelligence solutions for the life sciences industry, announced a suite of significant enhancements to the Sorcero Intelligence Platform. These updates underscore the organization's ongoing commitment to empowering the life sciences industry with cutting-edge tools that accelerate research, improve patient outcomes, and drive innovation in...
Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI
AIT365 News Desk -
Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosmetics manufacturers face by bringing innovations to market more quickly through AI.
Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries...
Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
AIT365 News Desk -
Nxera Pharma – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company designing antibodies for challenging targets, have announced a multi-target partnership and licensing agreement to design antibodies for G-protein coupled receptors (GPCRs).
The collaboration combines Antiverse’s generative AI antibody design expertise, including its proprietary...
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
AIT365 News Desk -
Absci Corporation a data-first generative AI drug creation company, and Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, unveiled a collaboration to design a novel therapeutic using generative AI.
“Bringing together two leaders in biotechnology innovation represents an opportunity...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive trial designs, and trial diversity....